跳至主要内容
临床试验/TCTR20160314002
TCTR20160314002招募中1 期

A pilot, comparison study of the treatment in acute attack of neuromyelitisoptica: Intravenous methylprednisolone versus plasma exchange alone

none0 个研究点目标入组 10 人开始时间: 2016年3月14日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 90 Years(—)
性别
All

入选标准

  • Diagnosis of neuromyelitis optica/neruomyelitis optica spectrum disorder
  • Admit at siriraj hospital during 2016-2017
  • Diagnosis of acute severe attack of NMO within 30 days
  • Severe attack was defined at least one of the following
  • Motor power grade ≤ 2 Medical research council for first attack
  • At least 2-point worsening in 1 of the pyramidal of functional system score (FSS) compared to last visit
  • At least 1-point worsening in EDSS score compared to last visit if previous EDSS score is 5.5 or more
  • Visual acuity ≤ 20/200 one eye
  • Glascow coma scale < 6
  • Hemodynamic instability or respiratory failure

排除标准

  • Previous treatment with intravenous steroid
  • Time to next relapse shorter than 90 days
  • Serious / uncontrolled infection
  • Hemodynamic unstable

研究者

发起方
none

相似试验